Scilex Holding Company was incorporated in Delaware in February 2019. The Company is an innovative revenue generating company focused on acquiring, developing and commercializing non-opioid drug management products for the treatment of acute and chronic pain. The company believes that the company's innovative non-opioid product portfolio has the potential to provide effective pain management therapies that can have a transformative impact on patients' lives. The company is committed to advancing and improving patient outcomes by targeting indications with high unmet needs and large market opportunities for non-opioid therapies in patients with acute and chronic pain.